ICER Archives - Bionest

2

Dec 2019

Bionest

The Relationship Between ICER and Industry is Evolving

ICER is expected to update the assessment framework underpinning its evidence reports on new drugs and health care interventions at the end of this year. What changes are likely to be made?

1

Oct 2018

Bionest

The Growing Influence of ICER

We have previously written about the Institute for Clinical and Economic Review (ICER), the independent watchdog whose mission is to offer an objective evaluation of the clinical and economic value of prescription drugs, medical tests, and other healthcare innovations. Many European nations have governmental or quasi-governmental agencies, like the United Kingdom’s NICE (the National...

4

Jun 2018

Bionest

Vertex Under Fire

The Institute for Clinical & Economic Review (ICER) recently ruled that all three of Vertex’s cystic fibrosis (CF) drugs are considerably overpriced. ICER analyzed the prices for Kalydeco, Orkambi, and new treatment Symdeko based on a metric called “quality-adjusted life year,” which factors in both the quantity and the quality of life lived. While ICER...